MCF-7 cells were instead selected to develop the in vivo model because their moderate HER2 expression could allow us to better appreciate differences in tumour recognition and accumulation of 5NP-1Tz versus 5NP-2Tz. The gene discussed is ERBB2; the disease is neoplasm.